The need for hypoglycemia detection and prevention in type 1 diabetes

Diabetes Technology and Therapeutics

Volumn 3, Issue 4, 2001, Pages 567-570

  Klonoff, David C ^a  

^a DIABETES RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; GLUCAGON; GLUCOSE; GROWTH HORMONE; HEMOGLOBIN A1C; HYDROCORTISONE; INSULIN;

BIOCOMPATIBILITY; BLOOD GLUCOSE MONITORING; BRAIN INJURY; DEVICE; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DISEASE SEVERITY; EDITORIAL; ELECTROENCEPHALOGRAM; GLUCAGON RELEASE; GLUCOSE ASSAY; GLUCOSE BLOOD LEVEL; HEART VENTRICLE ARRHYTHMIA; HIGH RISK POPULATION; HORMONAL REGULATION; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; NEUROLOGIC DISEASE; PRIORITY JOURNAL; REFERENCE VALUE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SENSOR; VISUAL ACUITY;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; EPINEPHRINE; GLUCAGON; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; HYPOGLYCEMIA; LABORATORIES, HOSPITAL; REPRODUCIBILITY OF RESULTS;

EID: 0035723552     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/15209150152811180     Document Type: Editorial

References (23)

1. Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms
2. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction
3. Roles of glucagon and epinephrine in hypoglycemic and non-hypoglycemic glucose counterregulation in humans
4. Growth hormone, cortisol, or both are involved in defense against, but are not critical to recovery from, hypoglycemia
5. Incidence of hypoglycemic episodes in diabetic patients under continuous subcutaneous insulin infusion and intensified conventional insulin treatment: Assessment by means of semiambulatory 24-hour continuous blood glucose monitoring
6. Frequency of daytime biochemical hypoglycaemia in insulin-treated diabetic patients: Relation to daily median blood glucose concentrations
7. Nocturnal hypoglycemia in children and adolescents with insulin-dependent diabetes mellitus: Prevalence and risk factors
8. Unsuspected nocturnal hypoglycemia detected with an insulin pump and continuous glucose monitor
9. Symptomatic hypoglycaemia in 411 type 1 diabetic patients
10. How well are we doing? Metabolic control in patients with diabetes
11. Frequency of severe hypoglycaemia in type 1 and type 2 diabetes during conventional insulin therapy
12. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
13. Should the same glucose values be targeted for type 1 as for type 2 diabetics in pregnancy?
14. Autonomic mediation of glucagon secretion during hypoglycemia: Implications for impaired alpha-cell responses in type 1 diabetes
15. Effect of hypoglycemia on beta-adrenergic sensitivity in normal and type 1 diabetic subjects
16. Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy
17. Dead-in-bed syndrome in young diabetic patients
18. Is undetected autonomic dysfunction responsible for sudden death in type 1 diabetes mellitus? The "dead in bed" syndrome revisited
19. Metabolic and cutaneous events associated with hypoglycemia detected by sleep sentry
20. Monitoring set-up for selection of parameters for detection of hypoglycaemia in diabetic patients
21. Blood glucose dependence of visual flicker threshold
22. Detection of hypoglycemia with the GlucoWatch® biographer
23. Detection of postprandial hyperglycemia using the GlucoWatch® biographer